» Articles » PMID: 30706299

A Silk Fibroin/decellularized Extract of Wharton's Jelly Hydrogel Intended for Cartilage Tissue Engineering

Overview
Journal Prog Biomater
Date 2019 Feb 2
PMID 30706299
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

A hybrid hydrogel was obtained from decellularized extract from Wharton's jelly (DEWJ) and silk fibroin (SF) and characterized for cartilage tissue engineering. Wharton's jelly was used due to its similarity with articular cartilage in extracellular matrix composition. Also, silk fibroin has good mechanical properties which make this construct appropriate for cartilage repair. Decellularization of Wharton's jelly was verified by DAPI staining, DNA quantification, and PCR analysis. Then, the biochemical composition of DEWJ was determined by ELISA kits for total proteins, collagens, sulfated glycosaminoglycans (sGAG), and transforming growth factor β1 (TGF-β1). After fabricating pure SF and SF/DEWJ hybrid hydrogels, their physical and mechanical properties were characterized by FESEM, Fourier-transform infrared spectroscopy (FTIR) and rheological assays (amplitude and frequency sweeps). Furthermore, cell viability and proliferation were assessed by MTT assay. The results have shown that DEWJ in hybrid hydrogels enhances mechanical properties of the construct relative to pure SF hydrogels. Also, this extract at its 40% concentration in culture media and 20% or 40% concentrations in SF/DEWJ hybrid hydrogels significantly increases population of the cells compared to control and pure SF hydrogel after 7 days. In conclusion, this study proposes the potential of SF/DEWJ hybrid hydrogels for cartilage tissue engineering applications.

Citing Articles

Decellularized Umbilical Cord as a Scaffold to Support Healing of Full-Thickness Wounds.

Kondratenko A, Tovpeko D, Volov D, Kalyuzhnaya L, Chernov V, Glushakov R Biomimetics (Basel). 2024; 9(7).

PMID: 39056846 PMC: 11274938. DOI: 10.3390/biomimetics9070405.


Derivation and Characterization of Novel Cytocompatible Decellularized Tissue Scaffold for Myoblast Growth and Differentiation.

Singh A, Singh S, Kumar V, Gupta J, Kumar M, Sarma D Cells. 2024; 13(1).

PMID: 38201245 PMC: 10778107. DOI: 10.3390/cells13010041.


Successful 3D culture and transplantation of mouse isolated preantral follicles in hydrogel of bioengineered Wharton's jelly.

Zand E, Rajablou E, Siadat S, Beiki B, Akbarinejad V, Amorim C PLoS One. 2023; 18(9):e0290095.

PMID: 37729236 PMC: 10511077. DOI: 10.1371/journal.pone.0290095.


Application of Silk-Fibroin-Based Hydrogels in Tissue Engineering.

Lyu Y, Liu Y, He H, Wang H Gels. 2023; 9(5).

PMID: 37233022 PMC: 10218181. DOI: 10.3390/gels9050431.


Glucose-Responsive Silk Fibroin Microneedles for Transdermal Delivery of Insulin.

Tan G, Jiang F, Jia T, Qi Z, Xing T, Kundu S Biomimetics (Basel). 2023; 8(1).

PMID: 36810381 PMC: 9944804. DOI: 10.3390/biomimetics8010050.


References
1.
Sobolewski K, Malkowski A, Bankowski E, Jaworski S . Wharton's jelly as a reservoir of peptide growth factors. Placenta. 2005; 26(10):747-52. DOI: 10.1016/j.placenta.2004.10.008. View

2.
Wolff E, Wolff A, Du H, Taylor H . Demonstration of multipotent stem cells in the adult human endometrium by in vitro chondrogenesis. Reprod Sci. 2007; 14(6):524-33. DOI: 10.1177/1933719107306896. View

3.
Wang X, Kluge J, Leisk G, Kaplan D . Sonication-induced gelation of silk fibroin for cell encapsulation. Biomaterials. 2007; 29(8):1054-64. PMC: 2693043. DOI: 10.1016/j.biomaterials.2007.11.003. View

4.
Malkowski A, Sobolewski K, Jaworski S, Bankowski E . TGF-beta binding in human Wharton's jelly. Mol Cell Biochem. 2008; 311(1-2):137-43. DOI: 10.1007/s11010-008-9704-x. View

5.
Uebersax L, Merkle H, Meinel L . Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release. 2008; 127(1):12-21. DOI: 10.1016/j.jconrel.2007.11.006. View